A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV

Antiviral Chemistry and Chemotherapy

Volumn 16, Issue 2, 2005, Pages 129-134

  Oxford, John S ^a   Lambkin, Robert ^a   Gibb, Iain ^b   Balasingam, Shobana ^a   Chan, Charlotte ^a   Catchpole, Andrew ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b The Boots Company PLC   (United Kingdom)

Author keywords

Influenza A; Respiratory syncytial virus; Rhinovirus; SARS CoV; Throat lozenge

Indexed keywords

AMYLMETACRESOL; ANTIVIRUS AGENT; BENZYL ALCOHOL DERIVATIVE; DICHLOROBENZYL ALCOHOL; META CRESOL; STREPSIL; UNCLASSIFIED DRUG; CRESOL;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; ELECTRON MICROSCOPY; INFLUENZA VIRUS A; LOZENGE; MORPHOLOGY; NONHUMAN; PH; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SARS CORONAVIRUS; THROAT; VIRUS ENVELOPE; DRUG COMBINATION; DRUG DOSAGE FORM; DRUG EFFECT; HUMAN;

ADENOVIRIDAE; ANTIVIRAL AGENTS; BENZYL ALCOHOLS; CRESOLS; DOSAGE FORMS; DRUG COMBINATIONS; HUMANS; INFLUENZA A VIRUS; RESPIRATORY SYNCYTIAL VIRUSES; RHINOVIRUS; SARS VIRUS;

EID: 23244438368     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020501600205     Document Type: Article

References (24)

1. Al-Jabri AA, Wigg MD & Oxford JS (1996) Initial in vitro screening of drug candidates for their potential antiviral activities. In Virology Methods Manual; pp. 293-308. Edited by BMJ Mahy & Kangro HO. London: Academic Press.
2. Bridges CB, Lim VV, Hu-Primmer J, Sims L, Fukuda K, Mak KH, Rowe T, Thompson WW, Conn L, Lu XH, Cox NJ & Katz JM (2002) Risk of influenza A (H5N1) influenza among poultry workers in Hong Kong, 1997-1998. Journal of Infectious Diseases 185:205-210.
3. Collier L & Oxford JS (2002) In Human Virology: a Text for Students of Medicine. 2nd edition. Oxford: Oxford University Press, pp. 284.
4. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H & Doerr HW (2003) Identification of a novel coronavirus associated with severe acute respiratory syndrome. New England Journal of Medicine 348:1967-1976.
5. Gubareva LV, Kaiser L & Hayden FG (2000) Influenza virus neuraminidase inhibitors. Lancet 355:827-835.
6. Gwaltney JM & Hendley JO (1982) Transmission of experimental rhinoviruses infection by contaminated surfaces. American Journal of Epidemiology 116:828-833.
7. Haagmans BL, Kuiken T, Martina BE, Fouchier RAM, Rimmelzwaan GF, Ameringen G, van Riel D, de Jong T, Itamura S, Chan K-H, Tashro M & Osterhaus ADME (2004) Pegylated interferon alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nature Medicine (in press).
8. Keller MJ, Klotman HE & Herold BC (2003) Rigorous preclinical evolution of topical microbicides to prevent transmission of human immunodeficiency virus. Journal of Antimicrobial Chemotherapy 51:1099-1102.
9. Kim CU, Lew W & Williams MA (1997) Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis and structural analysis of carbocyclic sialic acid analogues with patent anti influenza activity. Journal of the American Chemical Society 119:681-690.
10. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, Lui SF, Szeto CC, Chung S & Sung JJY (2003) A major outbreak of severe acute respiratory syndrome in Hong Kong. New England Journal of Medicine 368:1896-1994.
11. McDonnell G & Russell AD (1999) Antiseptic and disinfectants: activity, action and resistance. Clinical Microbiology Reviews 12:147-179.
12. Oxford JS, Potter CW, McLaren CW & Hardy W (1971) Inactivation of influenza and other viruses by a mixture of virucidal compounds. Applied Microbiology 21:606-610.
13. Oxford JS & Galbraith A (1987) Anti influenza virus activity of amantadine: a selective review of laboratory and clinical data. In Antiviral Chemotherapy, vol 1; pp. 169-254. Edited by D Shugar. Oxford: Pergamon Press.
14. Oxford JS, Zuckerman MA, Race E, Dourmashkin R, Broadhurst K & Sutton PM (1994) Sodium deoxycholate exerts a direct virus disruptive effect on HIV and influenza viruses in vitro and inhibits retrovirus induced pathology in an animal model. Antiviral Chemistry & Chemotherapy 5:176-181.
15. Oxford JS, Novelli P, Sefton A & Lambkin R (2002) New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors. Antiviral Chemistry & Chemotherapy 13:205-217.
16. Oxford JS, Bossuyt S & Lambkin R (2003) A new infectious disease challenge: severe, acute respiratory syndrome (Urbani SARS) associated coronavirus. Immunology 109:326-328.
17. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT, Cheng VCC, Chan KH, Tsang DNC, Yung RWH, TK Ng, Yuen KY & members of the SARS study group (2003a) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 261:1319-1325.
18. Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, LLM Poon, Law KI, Tang BSF, Hon TYW, Chan CS, Chan KH, Ng JSC, Zheng BJ, Ng WL, Lai RWM, Guan Y, Yuen KY & members of the HKU/UCH SARS Study Group (2003b) Clinical progression and viral load in a community outbreak of coronavirus associated SARS pneumonia: a prospective study. Lancet 361:1767-1772.
19. Pitts J & Vincent SH (1988) Diagnostic labels, treatment and outcome in acute sore throat. Practitioner 232:343-346.
20. Stuart-Harris CH, Schild GC & Oxford JS (1985) Influenza: the Virus and the Disease. London: Edward Arnold.
21. Tyrrell DAJ (1965) Common Colds and Related Diseases. London: Edward Arnold.
22. Hien TT, Liem NT, Dung NT, San LT, Mai PP, Chau NvV, Suu PT, Dong VC, Mai LTQ, THi NT, Khoa DB, Phat LP, Truong NT, Long HT, Tung CV, Giang LT, Tho ND, Nga LH, Tien NTK, San LH, Tuan LV, Dolecek C, Thanh TT, de Jong M, Schultsz C, Cheng P, Lim W, Horby P, the WHO International Avian Influenza Investigative Team & Farrar J (2004) Avian influenza (H5N1) in 10 patients in Vietnam. New England Journal of Medicine 350:1179-1188.
23. Von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Phan TV, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR (1993) Rational design of a potent sialidase based inhibitor of influenza virus replication. Nature 363:418-423.
24. Van Kolfschooten F (2003) Dutch veterinarian becomes first victim of avian influenza. Lancet 361:1444.